26PA combination of resistance mechanisms is frequent in...

Annals of Oncology 2019 / 11 Vol. 30; Iss. Supplement

26PA combination of resistance mechanisms is frequent in non-small cell lung cancer (NSCLC) that progressed to EGFR tyrosine kinase inhibitors (TKIs)

Enrico, D H, Lacroix, L, Rouleau, E, Scoazec, J-Y, Loriot, Y, Tselikas, L, Jovelet, C, Planchard, D, Gazzah, A, Mezquita, L, Ngo, M, Michiels, S, Maillard, A, Massard, C, Facchinetti, F, Soria, J-C, A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz413.031
Date:
November, 2019
File:
PDF, 89 KB
2019
Conversion to is in progress
Conversion to is failed